Biomeme

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://biomeme.com/

Last Round

VC Round

Dec 20, 2021

Total Funding Raised

$5.45M

Company Overview

Biomeme is a diagnostic equipment company that manufactures a mobile platform for real-time DNA and RNA testing outside of traditional laboratory settings.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Defense Tech, Environmental Monitoring

Business Model

B2G

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

portable PCRmolecular diagnosticspoint-of-care testingreal-time PCRbiodefense testingPOCTinfectious disease testingfield diagnosticsmachine learning diagnosticshost response testshelf-stable reagentsbacterial vs viral differentiationantibiotic stewardshipportable thermocyclerenvironmental monitoringlyophilized reagentsCBRN detectionCLIA lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomeme Comps

Public and private peers based on sector, stage, and business model.

Biomeme comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biomeme Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 20, 2021
Grant	Nov 30, 2021
Grant	Apr 9, 2021
VC Round	Mar 1, 2020
Seed	Jan 29, 2014
Accelerator	Aug 9, 2013

View all Funding Rounds

Key People

Founding team and executive leadership

Max Perelman

Co-Founder President And CEO

Founding Team

Biomeme Investors

Notable investors and investment history

Biomeme investors
Investor	Rounds
Defense Health Agency	Grant
Benjamin Franklin Technology Partners	Seed, VC Round
Bundesministerium für Bildung und Forschung	VC Round
Dreamit Ventures	Seed, Accelerator
Foundation for Innovative New Diagnostics	VC Round
Commonwealth of Pennsylvania	Grant
Independence Blue Cross	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 2, 2026
Monthly visitors increased 44% MoM to 4.5K.
May 4, 2025
Monthly visitors increased 53% MoM, reaching 2.3K.

View all signals

Biomeme Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biomeme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomeme's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range64

Year Founded2012

Last FundingDec 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.